GOVX vs TROW · $10.6M cap vs P/E 12, rev $3.76B
GeoVax Labs Inc (GOVX) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
GeoVax Labs Inc (GOVX) is a biotechnology company listed on US.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported GOVX revenue for 2026-06-30 was $0. Net income was -$9.7M. GOVX currently screens at market cap $10.6M.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
GOVX currently screens at market cap $10.6M. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the GOVX and TROW stock pages for the full models.
Not investment advice.